303 related articles for article (PubMed ID: 34955556)
1. Antiviral and Antimicrobial Nucleoside Derivatives: Structural Features and Mechanisms of Action.
Zenchenko AA; Drenichev MS; Il'icheva IA; Mikhailov SN
Mol Biol; 2021; 55(6):786-812. PubMed ID: 34955556
[TBL] [Abstract][Full Text] [Related]
2. [Antiviral and Antimicrobial Nucleoside Derivatives: Structural Features and Mechanisms of Action].
Zenchenko AA; Drenichev MS; Ilyicheva IA; Mikhailov SN
Mol Biol (Mosk); 2021; 55(6):897-926. PubMed ID: 34837696
[TBL] [Abstract][Full Text] [Related]
3. 5-(1-Substituted) alkyl pyrimidine nucleosides as antiviral (herpes) agents.
Kumar R
Curr Med Chem; 2004 Oct; 11(20):2749-66. PubMed ID: 15544474
[TBL] [Abstract][Full Text] [Related]
4. The antiviral activity and mechanism of action of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] (HPMP) nucleosides.
Magee WC; Evans DH
Antiviral Res; 2012 Nov; 96(2):169-80. PubMed ID: 22960154
[TBL] [Abstract][Full Text] [Related]
5. Human and viral nucleoside/nucleotide kinases involved in antiviral drug activation: structural and catalytic properties.
Deville-Bonne D; El Amri C; Meyer P; Chen Y; Agrofoglio LA; Janin J
Antiviral Res; 2010 Apr; 86(1):101-20. PubMed ID: 20417378
[TBL] [Abstract][Full Text] [Related]
6. 4'-Modified Nucleosides for Antiviral Drug Discovery: Achievements and Perspectives.
Chang J
Acc Chem Res; 2022 Feb; 55(4):565-578. PubMed ID: 35077644
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of Nucleosides and Non-nucleosides Based 4,6-disubstituted-2-oxo-dihydropyridine-3-carbonitriles as Antiviral Agents.
Ibrahim TS; El-Sayed HA; Khayat MT; Al-Mahmoudy AMM; Moustafa AH; El-Deen AKS; Rostom SAF; Panda SS
Med Chem; 2018; 14(8):791-808. PubMed ID: 29788895
[TBL] [Abstract][Full Text] [Related]
8. New tools in nucleoside toolbox of tick-borne encephalitis virus reproduction inhibitors.
Orlov AA; Drenichev MS; Oslovsky VE; Kurochkin NN; Solyev PN; Kozlovskaya LI; Palyulin VA; Karganova GG; Mikhailov SN; Osolodkin DI
Bioorg Med Chem Lett; 2017 Mar; 27(5):1267-1273. PubMed ID: 28159412
[TBL] [Abstract][Full Text] [Related]
9. Nucleoside Inhibitors of Coronaviruses.
Zenchenko AA; Drenichev MS; Mikhailov SN
Curr Med Chem; 2021; 28(26):5284-5310. PubMed ID: 33563148
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of nucleoside analogues for inhibition of tick-borne encephalitis virus.
Eyer L; Šmídková M; Nencka R; Neča J; Kastl T; Palus M; De Clercq E; Růžek D
Antiviral Res; 2016 Sep; 133():119-29. PubMed ID: 27476046
[TBL] [Abstract][Full Text] [Related]
11. New antiviral nucleoside prodrugs await application.
Anastasi C; Quéléver G; Burlet S; Garino C; Souard F; Kraus JL
Curr Med Chem; 2003 Sep; 10(18):1825-43. PubMed ID: 12871107
[TBL] [Abstract][Full Text] [Related]
12. Biocatalytic cascade transformations for the synthesis of C-nucleosides and N-nucleoside analogs.
Pfeiffer M; Nidetzky B
Curr Opin Biotechnol; 2023 Feb; 79():102873. PubMed ID: 36630750
[TBL] [Abstract][Full Text] [Related]
13. Antiviral nucleoside analogs.
Kataev VE; Garifullin BF
Chem Heterocycl Compd (N Y); 2021; 57(4):326-341. PubMed ID: 34007086
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of current and promising nucleosides for the treatment of human immunodeficiency viruses.
Schinazi RF; Hernandez-Santiago BI; Hurwitz SJ
Antiviral Res; 2006 Sep; 71(2-3):322-34. PubMed ID: 16716415
[TBL] [Abstract][Full Text] [Related]
15. Design of anti-HIV compounds: from nucleoside to nucleoside 5'-triphosphate analogs. Problems and perspectives.
Kukhanova M; Krayevsky A; Prusoff W; Cheng YC
Curr Pharm Des; 2000 Mar; 6(5):585-98. PubMed ID: 10788598
[TBL] [Abstract][Full Text] [Related]
16. Nucleobases and corresponding nucleosides display potent antiviral activities against dengue virus possibly through viral lethal mutagenesis.
Qiu L; Patterson SE; Bonnac LF; Geraghty RJ
PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006421. PubMed ID: 29672522
[TBL] [Abstract][Full Text] [Related]
17. Stealth nucleosides: mode of action and potential use in the treatment of viral diseases.
Daifuku R
BioDrugs; 2003; 17(3):169-77. PubMed ID: 12749753
[TBL] [Abstract][Full Text] [Related]
18. Resistance to a Nucleoside Analog Antiviral Drug from More Rapid Extension of Drug-Containing Primers.
Chen H; Lawler JL; Filman DJ; Hogle JM; Coen DM
mBio; 2021 Feb; 12(1):. PubMed ID: 33563814
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity reduction by O-nicotinoylation of antiviral 6-benzylaminopurine ribonucleosides.
Zenchenko AA; Oslovsky VE; Varizhuk IV; Karpova EV; Osolodkin DI; Kozlovskaya LI; Ishmukhametov AA; Drenichev MS
Toxicol In Vitro; 2022 Aug; 82():105355. PubMed ID: 35390475
[TBL] [Abstract][Full Text] [Related]
20. An AZT Analog with Strongly Pairing Ethynylpyridone Nucleobase and Its Antiviral Activity against HSV1.
Han J; Funk C; Eyberg J; Bailer S; Richert C
Chem Biodivers; 2021 Jan; 18(1):e2000937. PubMed ID: 33270983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
